Company News

MD&M Midwest 2026 Speaking Session | Medicept

Medicept — Thu, 23 Jul 2026 17:48:00 GMT

MD&M MidWest

October 28 - 29, 2026
Minneapolis Convention Center
Minneapolis, MN

MEDevice Boston 2026 Speaking Sessions | Medicept

Medicept — Thu, 23 Jul 2026 17:35:46 GMT

MEDevice Boston

August 26–27, 2026
Thomas M. Menino Convention & Exhibition Center
Boston, MA

Jason Gromek Appointed as MEDIcept President and CEO - MEDIcept

Medicept — Mon, 17 Mar 2025 13:00:00 GMT

To our Valued Colleagues and Clients,

MEDIcept and Pure Global Partner for IVD Market Access

cthomas — Wed, 07 Aug 2024 14:00:00 GMT

Jersey City & Boston, 2 May 2024 – Pure Global, a leader in global market access services, and MEDIcept, renowned for its expertise in US and EU regulatory, quality, and clinical services, proudly announce their strategic collaboration. This alliance aims to revolutionize the medical device and in vitro diagnostics (IVD) industry by combining their strengths to unlock new opportunities and streamline market access worldwide.

Pure Global and MEDIcept recognize the paramount importance of regulatory compliance and market access for global success in the medical device and IVD sectors. By joining forces, the two entities aim to leverage their expertise and networks to navigate regulatory complexities efficiently. Pure Global brings to the table extensive experience in global representation and registration services alongside their cutting-edge AIGC regulatory tools. On the other hand, MEDIcept boasts a solid reputation in regulatory, quality, and clinical services for the US and EU markets. Together, they provide comprehensive solutions ranging from regulatory affairs and quality assurance to clinical support and market representation across regions like the US, Latin America, Europe, the Middle East, and Asia Pacific.

This alliance is of significant importance to the industry as it unites two companies with complementary strengths, enhancing their ability to navigate regulatory landscapes and facilitate market access effectively. By pooling their expertise, Pure Global and MEDIcept aim to drive growth and innovation, ultimately benefiting their clients and the industry as a whole.

Pure Global and MEDIcept are aligned in their pursuit of several objectives through this collaboration:

Enhancing capabilities by leveraging respective networks and expertise
Expanding service offerings into additional regions, including the US, Europe, the Middle East, Latin America, and Asia-Pacific
Leveraging each other's strengths to bolster capacity and expertise
Designing pre- and post-market global clinical studies for comprehensive support
Empowering research efficiency through Pure Global's AIGC tools

Both Pure Global and MEDIcept will continue their operations with an expanded service portfolio. The collaboration will see the companies leveraging their combined resources to enhance efficiency and deliver greater value to their clients.

The initial action following the alliance will involve a collaborative marketing effort to promote each other's services. By working together, Pure Global and MEDIcept aim to advance the medical device industry and remove barriers to innovation.

“Pure Global's strategic alliance with MEDIcept will help accelerate MedTech innovation and streamline compliance. By combining their hundreds of successful submissions since 1996 with our AI-powered & data driven regulatory solutions, we empower clients worldwide to bring life-changing MedTech to market faster, with reduced costs and higher regulatory success.” said Zhu (Phyllis) Meng, CEO of Pure Global.

“With this strategic alliance we are strengthening our worldwide presence and can serve the needs of our customers anywhere. With teams of seasoned consultants both MEDIcept and Pure Global offer deep expertise across a wide range of compliance needs. Together, this relationship will efficiently help international companies with FDA and US quality, regulatory, clinical, and reimbursement concerns and rapidly provide tailored, trusted solutions to meet their unique challenges.” stated David Rothkopf, President of MEDIcept.

For media inquiries or further information, please contact:

Tove Berkhout – tove@prlab.co (Pure Global)

MEDIcept Marketing – marketing@medicept.com (MEDIcept)

About MEDIcept

Established in 1996, MEDIcept has been at the forefront of providing regulatory, quality, and clinical services for medical device and IVD manufacturers worldwide. MEDIcept’s relationships are built on Integrity and Communication to provide customized Innovative and Quality solutions in a Collaborative manner. With over 600 submissions, 1000 audits, 50 clinical trials, and a successful track record of remediation activities, MEDIcept is committed to driving success in the industry.

About Pure Global

Established in 2020, Pure Global has established itself as a reputable and experienced firm for the global market. As a leading & trusted global growth partner to MedTech companies, Pure Global delivers smart and efficient market access solutions powered by transformative data & technology. With over 300+ clients served globally and 1900+ global registration certificates, Pure Global is committed to advancing the industry.

MEDIcept Inc. Names New Managing Director and Vice President

Medicept — Tue, 01 Feb 2022 14:45:00 GMT

Ashland MA, February 1, 2022. MEDIcept Inc. announced today that Kim Trautman has been appointed as Managing Director and Vice President of the company. An experienced medical device, IVD, and combination product expert, Trautman worked at the US Food and Drug Administration (FDA) for 24 years and continues to work with Regulatory Agencies around the globe.

MEDIcept Acquires ACMP Clinical and Regulatory Consulting | Medicept

Medicept — Mon, 04 Jan 2021 14:00:00 GMT

Ashland, MA: MEDIcept Inc., an international quality, regulatory, and clinical consulting firm focused on medical device and in-vitro diagnostics (IVD), announces the acquisition of ACMP, a US-based privately held Clinical Research Organization (CRO) that provides full services for early phase, pre-, and post-market studies to the healthcare industry.

MEDIcept Inc. Announces Partnership with Arena Solutions | Medicept

Medicept — Mon, 07 Dec 2020 15:45:00 GMT

Ashland Massachusetts, December 4, 2020 – MEDIcept, Inc., a leading international medical device and IVD compliance consulting firm, today announced a new partnership with Arena Solutions, the leading provider of cloud-based product development solutions for high tech, consumer electronics, and medical device industries.

MEDIcept Acquires Quality Systems in Motion, Inc. (QSIM)

Medicept — Mon, 06 Jan 2020 15:15:00 GMT

For Immediate Release

Ashland, MA: MEDIcept Inc, an international quality, regulatory, and clinical consulting firm focused on medical device and in-vitro diagnostics (IVD), and QSIM, a US-based privately held consulting firm specializing in medical device/biotechnology, announces the merger of the two companies.

MEDIcept Now Offers CRO Services | Medicept

Medicept — Tue, 19 Nov 2019 16:45:00 GMT

November 14, 2019, Ashland, MA – MEDIcept Inc., a leading international Quality and Regulatory consulting firm focused on medical device and in-vitro diagnostics, and ACMP Consulting, Acton, MA have entered into an agreement to provide Clinical Research Organization (CRO) services for early phase, pre-, and post-market studies to the healthcare industry.

Medical Device Firms Merge to Form Comprehensive Services | Medicept

Medicept — Thu, 14 Mar 2019 14:00:00 GMT

Ashland, MA: MEDIcept Inc, a leading international quality and regulatory consulting firm focused on medical device and in-vitro diagnostics (IVD), and Reilly & Associates, a US-based privately held consulting firm specializing in medical device/biotechnology, announces the merger of the two companies.